Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Many advanced breast cancer patients do not receive postmastectomy radiation therapy

Forty-five percent of women with advanced breast cancer in the U.S. did not receive postmastectomy radiation therapy (PMRT) despite the publication of evidence-based guidelines outlining PMRT as a potentially lifesaving treatment, according to new research from The University of Texas MD Anderson Cancer Center.

28 Jun 2011

Pfizer to present PF-299 and crizotinib clinical trial data on ALK at WCLC 2011

Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio, including PF-00299804 an investigational, oral, pan-HER inhibitor; and crizotinib, an investigational, oral, first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK, at the International Association for the Study of Lung Cancer's 14th World Conference on Lung Cancer, July 3-7 in Amsterdam, The Netherlands.

28 Jun 2011

Breast cancer patients not getting recommended radiation therapy: Report

According to a report released Monday in the journal Cancer, nearly half of older women with advanced stage breast cancer who undergo a mastectomy don't receive radiation therapy, despite guidelines that say it can save lives.

28 Jun 2011

CTI added to Russell's U.S. indexes

Cell Therapeutics, Inc. announced today that it has been added to the Russell 3000, Russell 2000 and Russell Global Indexes posted by Russell Investments on June 27, 2011.

28 Jun 2011

Marshall Edwards' Triphendiol pre-clinical study data now available in Anti-Cancer Drugs website

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer.

28 Jun 2011

Researchers identify new lung stem cell that helps repair large airways

Researchers at UCLA have identified a new stem cell that participates in the repair of the large airways of the lungs, which play a vital role in protecting the body from infectious agents and toxins in the environment.

28 Jun 2011

Kindstar, Mayo Clinic enter multiyear agreement to offer specialized laboratory support

Mayo Clinic today announced that it has entered into a multiyear agreement with Wuhan Kindstar Globalgene Technology, Inc. (Kindstar) to provide specialized laboratory support based on provision of knowledge from Mayo Clinic's Department of Laboratory Medicine and Pathology and its reference laboratory, Mayo Medical Laboratories.

28 Jun 2011

Mayo Clinic signs agreement with Kindstar

Mayo Clinic today announced that it has entered into a multiyear agreement with Wuhan Kindstar Globalgene Technology, Inc. (Kindstar) to provide specialized laboratory support based on provision of knowledge from Mayo Clinic’s Department of Laboratory Medicine and Pathology and its reference laboratory, Mayo Medical Laboratories.

27 Jun 2011

Problems of unrecognized alcohol misuse among the elderly

The Royal College of Psychiatrists of London has published a report related primarily to problems of unrecognized alcohol misuse among the elderly. The report provides guidelines for psychiatrists and family physicians on how to find and how to treat elderly people with misuse of alcohol and drugs.

27 Jun 2011

EMA acceptance of brentuximab vedotin MAA triggers $5M milestone payment to Seattle Genetics

Seattle Genetics, Inc., today announced that it will receive a $5 million milestone payment under its brentuximab vedotin (ADCETRIS) collaboration with Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

27 Jun 2011

Genentech, FORMA enter structurally innovative agreement for small molecule cancer program

FORMA Therapeutics announced today that it entered into an agreement granting Genentech, a member of the Roche Group, exclusive worldwide rights to acquire a pre-clinical small molecule program against a single undisclosed cancer target.

27 Jun 2011

Flamel, Digna Biotech enter joint development agreement for multiple products

Flamel Technologies SA and Digna Biotech SL today announced that the two companies have entered into a joint development agreement for the pre-clinical and clinical development of multiple products.

27 Jun 2011

FDA responds to EpiCept Ceplene SPA

EpiCept Corporation today announced that it has received initial written responses from the U.S. Food and Drug Administration regarding the Company's application for a Special Protocol Assessment (SPA) of the Ceplene (histamine dihydrochloride) Phase III protocol.

27 Jun 2011

Endo recalls two lots of Endocet Tablets

Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count bottles, NDC 60951-712-70, Lot # 402415NV and #402426NV.

27 Jun 2011

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Over a decade ago, Canadian patients diagnosed with chronic myeloid leukemia (CML), celebrated when PrGleevec (imatinib mesylate) was approved in Canada.

27 Jun 2011

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

BioLineRx, a biopharmaceutical drug development company, and Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that they have signed a worldwide, exclusive license agreement for BioLineRx to develop and commercialize BL-7040, an orally available Phase II ready molecule for treating Inflammatory Bowel Disease (IBD) and other inflammatory diseases.

27 Jun 2011

Biota reports preliminary data from CS-8958 Phase III trial against influenza

Dr Seizaburo Kashiwagi presented the preliminary data from an influenza Phase III prophylaxis study conducted during the 2009/2010 pandemic flu season in Japan.

27 Jun 2011

Video monitors on public buses to help raise HIV testing awareness among African Americans

A University of Pennsylvania study will determine if public transit can convey more than people going from point A to point B. Video displays on public buses in Los Angeles will be used to help determine the efficacy of an innovative soap opera-like video program designed to increase HIV testing among low-income African Americans 14 to 24 years of age.

27 Jun 2011

EMA accepts Millennium's MAA for ADCETRIS to treat lymphoma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for ADCETRIS for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma.

27 Jun 2011

Astronomers to develop potential new cancer radiation treatment

Astronomers' research on celestial bodies may have an impact on the human body. Ohio State University astronomers are working with medical physicists and radiation oncologists to develop a potential new radiation treatment - one that is intended to be tougher on tumors, but gentler on healthy tissue.

27 Jun 2011

Oncology News and Research

Further Reading

Many advanced breast cancer patients do not receive postmastectomy radiation therapy

Pfizer to present PF-299 and crizotinib clinical trial data on ALK at WCLC 2011

Breast cancer patients not getting recommended radiation therapy: Report

CTI added to Russell's U.S. indexes

Marshall Edwards' Triphendiol pre-clinical study data now available in Anti-Cancer Drugs website

Researchers identify new lung stem cell that helps repair large airways

Kindstar, Mayo Clinic enter multiyear agreement to offer specialized laboratory support

Mayo Clinic signs agreement with Kindstar

Problems of unrecognized alcohol misuse among the elderly

EMA acceptance of brentuximab vedotin MAA triggers $5M milestone payment to Seattle Genetics

Genentech, FORMA enter structurally innovative agreement for small molecule cancer program

Flamel, Digna Biotech enter joint development agreement for multiple products

FDA responds to EpiCept Ceplene SPA

Endo recalls two lots of Endocet Tablets

Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

Biota reports preliminary data from CS-8958 Phase III trial against influenza

Video monitors on public buses to help raise HIV testing awareness among African Americans

EMA accepts Millennium's MAA for ADCETRIS to treat lymphoma

Astronomers to develop potential new cancer radiation treatment

Your guide to microplate readers for cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News